Performance and Validation of a New Long-Term Mortality Risk Score in Community-Acquired Pneumonia: A Colombian Cohort. [PDF]
Guerron-Gomez G +14 more
europepmc +1 more source
Mechanistic Insights into Maxing Shigan Decoction in Community-Acquired Pneumonia Based on Bioinformatics and Experimental Validation. [PDF]
Wei C +6 more
europepmc +1 more source
Health-related quality of life in community-acquired pneumonia: a prospective cohort study. [PDF]
Ryrsø CK +7 more
europepmc +1 more source
Respiratory multiplex PCR and antimicrobial treatment modification in hospitalized patients with community-acquired pneumonia. [PDF]
Çaşkurlu H +6 more
europepmc +1 more source
Pneumococcal community-acquired pneumonia in hospitalized adults in México 2018-2021: serotype distribution and clinical characteristics. [PDF]
Tinoco JC +14 more
europepmc +1 more source
Development and internal validation of a nomogram for predicting the severity of community-acquired pneumonia in children. [PDF]
Wang M +6 more
europepmc +1 more source
Adjunct Corticosteroids in Children With Community-Acquired Pneumonia Presenting to the Emergency Department: A Systematic Review and Meta-Analysis. [PDF]
Ahmed Elnour SE +6 more
europepmc +1 more source
Community-Acquired Pneumonia in Patients With Diabetes: Narrative Review. [PDF]
Xie Y, Zhang A, Wang Y, Wang R.
europepmc +1 more source
Severe community-acquired pneumonia: an integral approach. [PDF]
Asis A +6 more
europepmc +1 more source
Corticosteroids in severe community-acquired pneumonia: friend, foe or both? [PDF]
Carpenteri F, Cilloniz C, Torres A.
europepmc +1 more source

